1170 related articles for article (PubMed ID: 15949105)
21. Clinical long-term effects of Meniett pulse generator for Meniere's disease.
Huang W; Liu F; Gao B; Zhou J
Acta Otolaryngol; 2009 Aug; 129(8):819-25. PubMed ID: 18923942
[TBL] [Abstract][Full Text] [Related]
22. Effect of transtympanic low-pressure therapy in patients with unilateral Menière's disease unresponsive to betahistine: a randomised, placebo-controlled, double-blinded, clinical trial.
Gürkov R; Filipe Mingas LB; Rader T; Louza J; Olzowy B; Krause E
J Laryngol Otol; 2012 Apr; 126(4):356-62. PubMed ID: 22365373
[TBL] [Abstract][Full Text] [Related]
23. Functional outcome of treatment of Ménière's disease with the Meniett pressure generator.
Stokroos R; Olvink MK; Hendrice N; Kingma H
Acta Otolaryngol; 2006 Mar; 126(3):254-8. PubMed ID: 16618650
[TBL] [Abstract][Full Text] [Related]
24. 10-year review of endolymphatic sac surgery for intractable meniere disease.
Hu A; Parnes LS
J Otolaryngol Head Neck Surg; 2010 Aug; 39(4):415-21. PubMed ID: 20643008
[TBL] [Abstract][Full Text] [Related]
25. Meniett therapy may avoid vestibular neurectomy in disabling Meniere's disease.
Barbara M; Monini S; Chiappini I; Filipo R
Acta Otolaryngol; 2007 Nov; 127(11):1136-41. PubMed ID: 17851896
[TBL] [Abstract][Full Text] [Related]
26. [Long-term results of transtympanic gentamicin treatment in Meniere's disease].
Pierchała K; Krzeska-Malinowska I; Kowalska M; Bartoszewicz R; Niemczyk K
Otolaryngol Pol; 2005; 59(3):409-13. PubMed ID: 16117399
[TBL] [Abstract][Full Text] [Related]
27. Changes in audiometric thresholds before, during and after attacks of vertigo associated with Meniere's syndrome.
McNeill C; Cohen MA; Gibson WP
Acta Otolaryngol; 2009 Dec; 129(12):1404-7. PubMed ID: 19922089
[TBL] [Abstract][Full Text] [Related]
28. Summating potential and action potential ratio in Meniere's disease before and after treatment.
Orchik DJ; Shea JJ; Ge NN
Am J Otol; 1998 Jul; 19(4):478-82; discussion 483. PubMed ID: 9661758
[TBL] [Abstract][Full Text] [Related]
29. Long-term effect of transtympanic intermittent pressure therapy using a tympanic membrane massage device for intractable meniere's disease and delayed endolymphatic hydrops.
Shojaku H; Takakura H; Asai M; Fujisaka M; Ueda N; Do TA; Tsubota M; Watanabe Y
Acta Otolaryngol; 2021 Nov; 141(11):977-983. PubMed ID: 34689678
[TBL] [Abstract][Full Text] [Related]
30. Meniett device for Ménière's disease: use and compliance at 3 to 5 years.
Mattox DE; Reichert M
Otol Neurotol; 2008 Jan; 29(1):29-32. PubMed ID: 18199955
[TBL] [Abstract][Full Text] [Related]
31. [Short-term efficacy of semicircular canal occlusion in the treatment of intractable Meniere's disease].
Fan ZM; Zhang DG; Han YC; Wang HB
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 47(8):677-9. PubMed ID: 23141401
[TBL] [Abstract][Full Text] [Related]
32. Long-term results of endolymphatic mastoid shunt surgery in patients with intractable Ménière's disease.
Yu MS; Lee KS; Chung JW
Otolaryngol Head Neck Surg; 2009 Aug; 141(2):237-42. PubMed ID: 19643258
[TBL] [Abstract][Full Text] [Related]
33. Vestibular nerve section versus intratympanic gentamicin for Meniere's disease.
Hillman TA; Chen DA; Arriaga MA
Laryngoscope; 2004 Feb; 114(2):216-22. PubMed ID: 14755193
[TBL] [Abstract][Full Text] [Related]
34. Effects of transtympanic intermittent pressure therapy using a new tympanic membrane massage device for intractable Meniere's disease and delayed endolymphatic hydrops: a prospective study.
Shojaku H; Aoki M; Takakura H; Fujisaka M; Asai M; Tsubota M; Ito Y; Watanabe Y
Acta Otolaryngol; 2021 Oct; 141(10):907-914. PubMed ID: 34520288
[TBL] [Abstract][Full Text] [Related]
35. Effects of middle ear pressure changes on clinical symptoms in patients with Ménière's disease--a clinical multicentre placebo-controlled study.
Odkvist LM; Arlinger S; Billermark E; Densert B; Lindholm S; Wallqvist J
Acta Otolaryngol Suppl; 2000; 543():99-101. PubMed ID: 10908991
[TBL] [Abstract][Full Text] [Related]
36. Transtympanic gentamicin treatment in Meniere's disease: a preliminary report.
Kasemsuwan L; Jariengprasert C; Chaturapatranont S
J Med Assoc Thai; 2006 Jul; 89(7):979-85. PubMed ID: 16881430
[TBL] [Abstract][Full Text] [Related]
37. Analysis of hearing preservation after endolymphatic mastoid sac surgery for Meniere's disease.
Sun GH; Leung R; Samy RN; McAfee JS; Hearst MJ; Savage CR; Choo DI; Pensak ML
Laryngoscope; 2010 Mar; 120(3):591-7. PubMed ID: 20131368
[TBL] [Abstract][Full Text] [Related]
38. Influence of Meniett® treatment on hearing.
Barbara M; Lazzarino AI; Biagini M; Costa M; Monini S
Acta Otolaryngol; 2010 Nov; 130(11):1256-9. PubMed ID: 20446875
[TBL] [Abstract][Full Text] [Related]
39. High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results.
Hsieh LC; Lin HC; Tsai HT; Ko YC; Shu MT; Lin LH
Acta Otolaryngol; 2009 Dec; 129(12):1420-4. PubMed ID: 19922092
[TBL] [Abstract][Full Text] [Related]
40. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
Perez N; Boleas MS; Martin E
Audiol Neurootol; 2005; 10(2):69-78. PubMed ID: 15650298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
